BassNBrew
Footballguy
NextTwo weeks. Be patient.
NextTwo weeks. Be patient.
Another failed delivery.Now headed into week 8.Nasdaq uplift will take four weeks or so, we hope sooner.
I do believe someone mentioning....2 months is a more realistic timeframe. Granted we are at 2 weeks so like Moonlight mentioned...the lack of info raises concerns.https://www.proactiveinvestors.com/companies/news/924514/cytodyn-files-to-uplist-to-the-nasdaq-updates-on-coronavirus-trials-924514.html
July 15th -
Another failed delivery.Now headed into week 8.
Didn’t they initially say 6 to 8 weeks is the normal time frame, and then on the call and NP was pushing that he was hoping it was going to be closer to six......I do believe someone mentioning....2 months is a more realistic timeframe. Granted we are at 2 weeks so like Moonlight mentioned...the lack of info raises concerns.
And he had mentioned the NYSE in a cc around 3 weeks before this. They were so late to start this process. Big fail for sure.https://www.proactiveinvestors.com/companies/news/924514/cytodyn-files-to-uplist-to-the-nasdaq-updates-on-coronavirus-trials-924514.html
July 15th -
Another failed delivery.Now headed into week 8.
I'm more concerned about the Patterson piece that was supposed to be published two months ago.Didn’t they initially say 6 to 8 weeks is the normal time frame, and then on the call and NP was pushing that he was hoping it was going to be closer to six......
I still have 5k shares so still in the game. That said, I’m very happy that I got a bunch out over $5. No idea if Tuesday was another peak or not but it’s feels way better after watching it go below $3 after the first peak of $10 and then again under $3 after the second peak of $6.70 (sold 1/3 that day). If there’s no good news until potentially October, it’ll test $3 again. I’m still in but the low swings were bothering me too much and it was an easy way to increase my overall cash position since it went up while the market went down.Getzlaf15 said:I can't believe the lack of solidarity here with so many selling this week. I'm not selling until Otis' BIL sells. #BIL'sMatter
Mine filled at 4.45.Not to toot my horn too much, but I feel like I am getting a bit better at predicting this thing.
Down a bit today at the open, just like I thought. My buy order in at 4.38 after selling a portion at 4.88 yesterday.
we will see if it hits. If not today, then I think I can get it tomorrow if no news. Definitely will bid lower if a proactive vid comes out today.
Yah.Kind of a boring day.
The end of month vote is keeping Nadar and crew in line on the press.
It would be hard to vote yes if there isn't an approval of some sort in the pipeline.The end of month vote is keeping Nadar and crew in line on the press.
“Dr. Dhody will discuss the very successful FDA meeting concerning CytoDyn’s upcoming HIV BLA submission .... “The end of month vote is keeping Nadar and crew in line on the press.
It was successful almost assuredly because they believe they got what they needed to proceed and provide missing data. Nothing more.“Dr. Dhody will discuss the very successful FDA meeting concerning CytoDyn’s upcoming HIV BLA submission .... “
Such classic NP, this is either complete car salesman mode/BS or actual good news. And of course we have really no way of knowing until then.
They are acting like most of us wished they would. No complaints.It was successful almost assuredly because they believe they got what they needed to proceed and provide missing data. Nothing more.
The reverse split is effective after the close tomorrow.HGEN is reverse splitting tomorrow. Does anyone know if this happens before, during, or after trading?
I am going to buy a small amount, but I think this goes lower right after splitting and then will settle in for the FDA/trial wait.
No bet? Whats my odds?The reverse split is effective after the close tomorrow.
They are finally doing things right. Enjoy it.What do you guys make of the 9/16 call?
I'm thinking they've been told no for emergency use at least until interim analysis. If UK had granted approval news would be out a lot sooner. I don't think UK really needs any more time than a couple of days to look over the CD10 data, previous safety history in HIV patients, and make a decision.
I'm holding until interim analysis, but seems like CYDY is stuck in a rut.
Is another investor call necessary or typical of companies for this type of info?They are finally doing things right. Enjoy it.
Maybe they are ‘slow playing’ it. HahahahhaNo PR makes me a little wary of this info but if it's true, then it's positive.
According to this leronlimab is slated for a 12/1 PDUFA. That said it's not on some other FDA tracker I just looked at and there has been no PR so there is reason for skepticism.Care to post or cliff notes? Can't see the article.
its being said on the other board, notoriously full of pumpers, that this is false. The site is not accurate and that is a projected date that has been there for months.According to this leronlimab is slated for a 12/1 PDUFA. That said it's not on some other FDA tracker I just looked at and there has been no PR so there is reason for skepticism.
Also, LOL at the stock this AM.
This seems the most likely conclusion, indeed.its being said on the other board, notoriously full of pumpers, that this is false. The site is not accurate and that is a projected date that has been there for months.
So glad I sold 2/3 of what I had left over $5 on Monday. I’ve still got some skin in the game but just felt like this would be a no news week and peek before the calls with no news.HugeUpside said:Meh, what's another 9% loss at this point.
So glad I sold 2/3 of what I had left over $5 on Monday. I’ve still got some skin in the game but just felt like this would be a no news week and peek before the calls with no news.
I have no clue where this journey will end but it feels nice knowing I would have lost another almost $10k had I not sold.
HIV BLA = Potential good news... at least BLA seems to be still on track.The invited guests are Dr. Kush Dhody, Director of clinical trials at Amarex Clinical Research, CytoDyn’s clinical research organization, and Dr. Nicholas Agresti, whose patients received leronlimab under the U.S. Food and Drug Administration (FDA) emergency IND (eIND) program. Dr. Dhody will discuss the very successful FDA meeting concerning CytoDyn’s upcoming HIV BLA submission and Dr. Agresti will speak about the experience of his patients who received leronlimab.
CytoDyn will also provide an update on the ongoing discussions with the FDA and the U.K. Medicines & Healthcare product Regulatory Agency (MHRA) for leronlimab as a treatment for COVID-19.
What's the scoop on this damn thing. I'm still HODLing because of the reasons you cited a few weeks back but it's been painful as hell.Whyatt said:The reverse split is effective after the close tomorrow.
Seems like it's looking California but feeling MinnesotaWhat's the scoop on this damn thing. I'm still HODLing because of the reasons you cited a few weeks back but it's been painful as hell.
You still feeling optimistic?
I imagine it will be low 3s again before long. I plan to accumulate some more around that time.Sub-$4 again. Hello, old friend.